Cargando…
Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation
Mast cell (MC) activation is associated with myocardial ischemia reperfusion injury (MIRI). Suppression of MC degranulation might be a target of anti-MIRI. This study aimed to determine whether clemastine fumarate (CLE) could attenuate MIRI by inhibiting MC degranulation. A rat ischemia and reperfus...
Autores principales: | Meng, Shuqi, Sun, Xiaotong, Juan, Zhaodong, Wang, Mingling, Wang, Ruoguo, Sun, Lina, Li, Yaozu, Xin, Anran, Li, Shuping, Li, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430029/ https://www.ncbi.nlm.nih.gov/pubmed/34512339 http://dx.doi.org/10.3389/fphar.2021.704852 |
Ejemplares similares
-
Clemastine Fumarate Protects Against Myocardial Ischemia Reperfusion Injury by Activating the TLR4/PI3K/Akt Signaling Pathway
por: Yuan, Xiaoxiao, et al.
Publicado: (2020) -
Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021) -
Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021) -
Degranulation of gastrointestinal mast cells contributes to hepatic ischemia–reperfusion injury in mice
por: He, Zhigang, et al.
Publicado: (2018) -
Measurement and modeling of clemastine fumarate (antihistamine drug) solubility in supercritical carbon dioxide
por: Sodeifian, Gholamhossein, et al.
Publicado: (2021)